Exodus Point Capital Management, LP Nektar Therapeutics Transaction History

Exodus Point Capital Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$2.03 - $4.28 $936,745 - $1.98 Million	461,451 Added 1486.2%	492,500 $1.11 Million
Q3 2022 Nov 10, 2022	BUY	$3.04 - $5.14 $94,388 - $159,591	31,049 New	31,049 $99,000
Q2 2022 Aug 19, 2022	SELL	$3.17 - $6.17 $1.32 Million - $2.56 Million	-415,709 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.16 - $13.72 $1.64 Million - $5.42 Million	394,825 Added 1890.56%	415,709 $2.24 Million
Q4 2021 Feb 11, 2022	SELL	$10.83 - $18.41 $388,493 - $660,403	-35,872 Reduced 63.2%	20,884 $282,000

Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $180,261 - $259,841	13,792 Added 32.1%	56,756 $1.02 Million
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $709,765 - $876,465	42,964 New	42,964 $737,000
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $273,968 - $421,210	-16,544 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $535,533 - $646,239	-33,959 Reduced 67.24%	16,544 $281,000
Q3 2020 Nov 16, 2020	BUY	$16.59 - $24.79 $247,937 - $370,486	14,945 Added 42.03%	50,503 $838,000
Q2 2020 Aug 14, 2020	BUY	$16.86 - $23.44 $599,507 - $833,479	35,558 New	35,558 $824,000
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $597,307 - $1.15 Million	-41,279 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.87 - $23.12 $655,097 - $954,370	41,279 New	41,279 $891,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.